Cassie Jung - Sep 4, 2025 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Sep 4, 2025
Transactions value $
-$214,493
Form type
4
Date filed
9/8/2025, 07:06 PM
Previous filing
Mar 11, 2025
Next filing
Oct 17, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jung Cassie Chief Operating Officer C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN /s/ Lori Braender, as Attorney-In-Fact 2025-09-08 0001960154

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Options Exercise $78.8K +25K +8.46% $3.15 321K Sep 4, 2025 Direct F1
transaction AQST Common Stock Options Exercise $17.7K +25K +7.8% $0.71 346K Sep 4, 2025 Direct F1
transaction AQST Common Stock Sale -$311K -62.2K -18% $5.00 283K Sep 4, 2025 Direct F2
holding AQST Common Stock 2K Sep 4, 2025 by spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Non-Qualified Stock Option (right to buy) Options Exercise $0 -25K -100% $0.00 0 Sep 4, 2025 Common Stock 25K $3.15 Direct F1, F3
transaction AQST Non-Qualified Stock Option (right to buy) Options Exercise $0 -25K -100% $0.00 0 Sep 4, 2025 Common Stock 25K $0.71 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Cassie Jung is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.
F3 This option was granted on August 9, 2019 and is fully vested.
F4 This option was granted on August 5, 2022 and is fully vested.